Advances in CRISPR-based molecular biosensing: from pathogen detection to early tumor screening

Abstract

The Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated (CRISPR/Cas) system, with its programmable nucleic acid recognition and trans-cleavage-mediated signal amplification capabilities, has evolved from a gene-editing tool into a core technology for next-generation molecular biosensing. This review systematically elucidates the molecular mechanisms of this technology, focusing on the trans-cleavage activity of key proteins such as Cas12, Cas13, and Cas14, in conjunction with the functional characteristics of tool enzymes like Cas9, and the fluorescence, electrochemical, and colorimetric signal readout strategies they employ. Furthermore, this article provides a detailed summary of the application advancements of CRISPR biosensors in the rapid test of pathogens, including viruses, bacteria, and parasites, and early tumor screening, which encompasses the highly sensitive detection of various nucleic acid biomarkers, including gene mutation, methylation, fusion gene, and microRNA. Furthermore, this review summarizes the technological evolution of device integration, from fully automated, closed microfluidics to portable systems, to achieve point-of-care testing. Finally, the article proposes future development directions, including the integration of this technology with nanomaterials and artificial intelligence. This review aims to provide a systematic reference for the further development and application transformation of CRISPR molecular biosensing technology.

Keywords

CRISPR/Cas / molecular diagnostics / biosensing / electrochemical sensors / optical sensors / pathogen detection / early tumor screening / point-of-care testing

References

[1] Silva S,Johnston C,Abu-Raddad LJ.Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: a modeling study.PLoS Med2022;19:e1003938 PMCID:PMC9754187

[2] Bray F,Sung H.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024;74:229-63

[3] World Health Organization. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Available from: https://www.who.int/publications/i/item/9789240005105 [Last accessed on 27 May 2026]

[4] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[5] Wu Z.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention.JAMA2020;323:1239

[6] Wang H,Pease SA.Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.Lancet2022;399:1513-36

[7] Rolando JC,Walt DR.The present and future landscapes of molecular diagnostics.Annu Rev Anal Chem2024;17:459-74

[8] Barrangou R.CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity.Mol Cell2014;54:234-44 PMCID:PMC4025954

[9] Simeonov DR.CRISPR-based tools in immunity.Annu Rev Immunol2019;37:571-97

[10] Wang KC,Hubbard BP.CRISPR/Cas technologies for cancer drug discovery and treatment.Trends Pharmacol Sci2025;46:437-52

[11] Wei L,She Y.CRISPR/Cas multiplexed biosensing: advances, challenges, and perspectives.Anal Chem2025;97:11943-58

[12] Zhou X,Liu J.CRISPR/Cas system targeting RNA and its derivative technology.Yi Chuan2025;47:842-860

[13] Cao L,Lei C.Engineered CRISPR/Cas ribonucleoproteins for enhanced biosensing and bioimaging.Anal Chem2025;97:5866-79

[14] Navarro C,Duran P.CRISPR-Cas systems: a functional perspective and innovations.Int J Mol Sci2025;26:3645 PMCID:PMC12026748

[15] Zhou J,Seun Olajide J.CRISPR/Cas-based nucleic acid detection strategies: trends and challenges.Heliyon2024;10:e26179 PMCID:PMC10882038

[16] Hryhorowicz M,Zeyland J.Evolution of CRISPR/Cas systems for precise genome editing.Int J Mol Sci2023;24:14233 PMCID:PMC10532350

[17] Wang C,Wang Z,Deng Y.Point-of-care diagnostics for infectious diseases: from methods to devices.Nano Today2021;37:101092 PMCID:PMC7864790

[18] Liu R,Liu F.Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020.Clin Chim Acta2020;505:172-5 PMCID:PMC7094385

[19] Laleh S,Stadtmüller M,Medina-Sánchez M.Portable microfluidic impedance biosensor for SARS-CoV-2 detection.Biosens Bioelectron2023;236:115362 PMCID:PMC10170873

[20] Dai Y,Liu G.CRISPR mediated biosensing toward understanding cellular biology and point-of-care diagnosis.Angew Chem Int Ed2020;59:20754-66

[21] Chhipa AS,Patel S.CRISPR-Cas based diagnostic tools: Bringing diagnosis out of labs.Diagn Microbiol Infect Dis2024;109:116252

[22] Liang Y,Lv Y.A novel single-tube LAMP-CRISPR/Cas12b method for rapid and visual detection of zoonotic Toxoplasma gondii in the environment.Infect Dis Poverty2024;13:94 PMCID:PMC11629535

[23] Belo Dos Santos S, Van Tricht C, Lammertyn J, Spasic D. Zoonotic disease detection at the point-of-care: the best of RPA and CRISPR-Cas.Biosens Bioelectron2026;293:118139

[24] Mallozzi A,Ragazzini F.A biomolecular circuit for automatic gene regulation in mammalian cells with CRISPR technology.ACS Synth Biol2024;13:3917-25 PMCID:PMC11669156

[25] Liu Y,Yu G.One-tube RPA-CRISPR Cas12a/Cas13a rapid detection of methicillin-resistant Staphylococcus aureus.Anal Chim Acta2023;1278:341757

[26] Manghwar H,Zhang X.CRISPR/Cas system: recent advances and future prospects for genome editing.Trends Plant Sci2019;24:1102-25

[27] Kostyusheva A,Babin Y.CRISPR-Cas systems for diagnosing infectious diseases.Methods2022;203:431-46 PMCID:PMC8032595

[28] Hillary VE.A review on the mechanism and applications of CRISPR/Cas9/Cas12/Cas13/Cas14 proteins utilized for genome engineering.Mol Biotechnol2022;65:311-25 PMCID:PMC9512960

[29] Jiang F.CRISPR-Cas9 structures and mechanisms.Annu Rev Biophys2017;46:505-29

[30] Smith QM,Aramayo RJ.Structural basis of supercoiling-induced CRISPR-Cas9 off-target activity.Nature2026;653:627-35 PMCID:PMC13171457

[31] Pardee K,Takahashi MK.Rapid, low-cost detection of zika virus using programmable biomolecular components.Cell2016;165:1255-66

[32] Tyumentseva M,Akimkin V.CRISPR/Cas9 landscape: current state and future perspectives.Int J Mol Sci2023;24:16077 PMCID:PMC10671331

[33] Yan F,Zhang J.CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.Cell Biol Toxicol2019;35:489-92

[34] Singh M,Misra CS.The era of Cas12 and Cas13 CRISPR-based disease diagnosis.Crit Rev Microbiol2022;48:714-29

[35] Li X,Shi C.CRISPR-Cas systems in DNA functional circuits: Strategies, challenges, prospects.Chin Chem Lett2025;36:110507

[36] Badon IW,Kim H.Recent application of CRISPR-Cas12 and OMEGA system for genome editing.Mol Ther2024;32:32-43 PMCID:PMC10787141

[37] Yu H,Liu C.CRISPR-Cas12a2-based rapid and sensitive detection system for target nucleic acid.Int J Biol Macromol2025;290:138996

[38] Chen JS,Harrington LB.CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.Science2018;360:436-9 PMCID:PMC6628903

[39] Zhuang S,Zhou H.CRISPR-HOLMES-based NAD+ detection.Front Bioeng Biotechnol2024;12:1355640 PMCID:PMC10999544

[40] Li S,Wang J.CRISPR-Cas12a-assisted nucleic acid detection.Cell Discov2018;4:20 PMCID:PMC5913299

[41] Li L,Wu N.HOLMESv2: a CRISPR-Cas12b-assisted platform for nucleic acid detection and DNA methylation quantitation.ACS Synth Biol2019;8:2228-37

[42] Scholz P,Crosby KT.RNA-triggered cell killing with CRISPR-Cas12a2.Nature2026;10466

[43] Yang H.Structures, mechanisms and applications of RNA-centric CRISPR-Cas13.Nat Chem Biol2024;20:673-88 PMCID:PMC11375968

[44] Gootenberg JS,Lee JW.Nucleic acid detection with CRISPR-Cas13a/C2c2.Science2017;356:438-42 PMCID:PMC5526198

[45] Kellner MJ,Gootenberg JS,Zhang F.SHERLOCK: nucleic acid detection with CRISPR nucleases.Nat Protoc2019;14:2986-3012 PMCID:PMC6956564

[46] Gootenberg JS,Kellner MJ,Collins JJ.Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.Science2018;360:439-44 PMCID:PMC5961727

[47] Harrington LB,Chen JS.Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.Science2018;362:839-42 PMCID:PMC6659742

[48] Aquino-Jarquin G.CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic.Nanomed Nanotechnol Biol Med2019;18:428-31

[49] Zhuang S,Liu Y.CRISPR-based SNP detection technologies advance from classical methods to cutting-edge innovations.Chem Commun2025;61:13345-58

[50] Khmeleva S,Kurbatov L.Biosensing platforms for DNA diagnostics based on CRISPR/Cas nucleases: towards the detection of nucleic acids at the level of single molecules in non-laboratory settings.Biomed Khim2024;70:287-303

[51] Sardaru M,Palumbo R,Rotaru A.Nucleic acid probes in bio-imaging and diagnostics: recent advances in ODN-based fluorescent and surface-enhanced raman scattering nanoparticle and nanostructured systems.Molecules2023;28:3561 PMCID:PMC10141977

[52] Min Y,Kim C,Shin Y.Split probe-induced protein translational amplification for nucleic acid detection.ACS Appl Bio Mater2024;7:8389-97

[53] Chen Z,Ren J.Recent advances in and application of fluorescent microspheres for multiple nucleic acid detection.Biosensors2024;14:265 PMCID:PMC11201543

[54] Li P,Yang Z.Rapid fluorescent nucleic acid sensing with ultra-thin gold nanosheets.Anal Chim Acta2024;1317:342872

[55] Lee I,Sorci M,Dordick JS.Highly sensitive immuno-CRISPR assay for CXCL9 detection.Anal Chem2021;93:16528-34 PMCID:PMC9012118

[56] Shi N,Zhang J.Accurate expression of neck motion signal by piezoelectric sensor data analysis.Chin Chem Lett2024;35:109302

[57] Wu C,Li C.CRISPR-Cas12a-empowered electrochemical biosensor for rapid and ultrasensitive detection of SARS-CoV-2 delta variant.Nano Micro Lett2022;14:159 PMCID:PMC9352833

[58] Wu L,Wu C.Ultrasensitive SARS-CoV-2 diagnosis by CRISPR-based screen-printed carbon electrode.Anal Chim Acta2022;1221:340120 PMCID:PMC9249825

[59] Dong J,Zhou S.Tri-mode CRISPR-based biosensor for miRNA detection: enhancing clinical diagnostics with cross-validation.Anal Chem2025;97:10938-46

[60] Wang W,Dai C.Amplification-free detection of Mycobacterium tuberculosis using CRISPR-Cas12a and graphene field-effect transistors.Nanoscale2025;17:4603-9

[61] Yang R,Zhang J.Quencher-free CRISPR-based molecular detection using an amphiphilic DNA fluorescence probe.Biosens Bioelectron2025;271:117054 PMCID:PMC11700774

[62] Kim J,Kim H.CRISPR/Cas13a-assisted amplification-free miRNA biosensor via dark-field imaging and magnetic gold nanoparticles.Sens Diagn2024;3:1310-8 PMCID:PMC11308380

[63] Tian T,Jiang Y,Zhou X.Exploiting the orthogonal CRISPR-Cas12a/Cas13a trans-cleavage for dual-gene virus detection using a handheld device.Biosens Bioelectron2022;196:113701

[64] Liu H,Xiu L.One-pot isothermal nucleic acid amplification assisted CRISPR/Cas detection technology: challenges, strategies, and perspectives.Adv Sci2025;12:e06716 PMCID:PMC12499467

[65] Song J,Moon J.Smartphone-based SARS-CoV-2 and variants detection system using colorimetric DNAzyme reaction triggered by loop-mediated isothermal amplification (LAMP) with clustered regularly interspaced short palindromic repeats (CRISPR).ACS Nano2022;16:11300-14 PMCID:PMC9236205

[66] Park S,Cho SM.Recent applications, future perspectives, and limitations of the CRISPR-Cas system.Mol Ther Nucl Acids2025;36:102634 PMCID:PMC12329533

[67] Broughton JP,Yu G.CRISPR-Cas12-based detection of SARS-CoV-2.Nat Biotechnol2020;38:870-4 PMCID:PMC9107629

[68] Joung J,Saito M.Detection of SARS-CoV-2 with SHERLOCK one-pot testing.N Engl J Med2020;383:1492-4 PMCID:PMC7510942

[69] Ibor O, Bassey E, Agu CM, Mirinn KE. Review on gene and cell therapies in prostate cancer treatment: prospects and challenges.J Transl Genet Genom2025;9:62-75

[70] Ganbaatar U.CRISPR-based COVID-19 testing: toward next-generation point-of-care diagnostics.Front Cell Infect Microbiol2021;11:663949 PMCID:PMC8120276

[71] Yin W,Yang Y.Ultra-sensitive detection of the SARS-CoV-2 nucleocapsid protein via a clustered regularly interspaced short palindromic repeat/Cas12a-mediated immunoassay.ACS Sens2024;9:3150-7

[72] Tian Y,Xu L.CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients.Emerg Microbes Infect2023;12:e2177088 PMCID:PMC9946317

[73] Sam IK,Ma J.TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.J Infect2021;83:54-60

[74] Shen Y,Hao G.A CRISPR/Cas12a-based direct transverse relaxation time biosensor via hydrogel sol-gel transition for Salmonella detection.Food Chem2025;470:142693

[75] Patel AK,Sachan N.Advancing antibacterial strategies: CRISPR-phage-mediated gene therapy targeting bacterial resistance genes.Curr Gene Ther2025;25

[76] Wei H,Liu Y.Rapid and ultrasensitive detection of Plasmodium spp. parasites via the RPA-CRISPR/Cas12a platform.ACS Infect Dis2023;9:1534-45

[77] Zhu H,Li Y.Rapid detection of mutations in the suspected piperaquine resistance gene E415G-exo in Plasmodium falciparum exonuclease via AS-PCR and RAA with CRISPR/Cas12a.Int J Parasitol Drugs Drug Resist2024;26:100568 PMCID:PMC11550206

[78] Sidik SM,Ganesan SM.A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes.Cell2016;166:1423-35.e12 PMCID:PMC5017925

[79] Musunuru K,Wang X.Patient-specific in vivo gene editing to treat a rare genetic disease.N Engl J Med2025;392:2235-43

[80] Park SH.CRISPR/Cas9 gene editing for curing sickle cell disease.Transfus Apher Sci2021;60:103060 PMCID:PMC8049447

[81] Bai L,Wang T.SPEAR: CRISPR-mediated ultrasensitive, specific and rapid one-pot detection strategy for cancer-related SNPs.Theranostics2025;15:3275-88 PMCID:PMC11905141

[82] Etemadzadeh A,Motlagh FM.An optimized CRISPR/Cas12a assay to facilitate the BRAF V600E mutation detection.J Clin Lab Anal2024;38:e25101 PMCID:PMC11555610

[83] Yu Y,Yuan W.Engineered crRNA drives RPA-T7-CRISPR/Cas14a cascade for ultrasensitive detection of ctDNA PIK3CA H1047R.Adv Sci2025;12:e07126 PMCID:PMC12667487

[84] Sun X,Jiang H,Zhou S.Accurate diagnosis of colorectal cancer using a combination of lectin-induced recombinase polymerase amplification and CRISPR/Cas12a assay on a point-of-care testing platform with deep learning assistant.Anal Chem2025;97:13086-94

[85] Jin L,Nie L,Khana GJ.Chitosan nanoparticles act as promising carriers of microRNAs to brain cells in neurodegenerative diseases.Chin Chem Lett2025;36:110774

[86] Wei W,Hao T.DNA walker-mediated biosensor for target-triggered triple-mode detection of Vibrio parahaemolyticus.Biosens Bioelectron2021;186:113305

[87] Tian Y,Zhang X.CRISPR/Cas13a-assisted accurate and portable hepatitis D virus RNA detection.Emerg Microbes Infect2023;12:2276337 PMCID:PMC10796118

[88] Xu J,Zhang J.Single-droplet dual-target quantification of circRNA biomarkers for colorectal cancer screening.Adv Sci2025;12:e06159 PMCID:PMC12520571

[89] Fu Y,Chen F.CRISPR detection of cardiac tumor-associated microRNAs.Mol Biol Rep2025;52:114

[90] Singh A.Effective downregulation of BCR-ABL tumorigenicity by RNA targeted CRISPR-Cas13a.Curr Gene Ther2021;21:270-7

[91] Bao M,Xu Z.Challenges and opportunities for clustered regularly interspaced short palindromic repeats based molecular biosensing.ACS Sens2021;6:2497-522

[92] Bhatia S,Yadav SK.CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.Int J Biol Macromol2023;238:124054

[93] Kaur R,Chauhan A,Sharma MK.Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics.Mol Biol Rep2024;51:896

[94] Ge H,Huang L.Development of a highly sensitive, high-throughput and automated CRISPR-based device for the contamination-free pathogen detection.Biosens Bioelectron2025;278:117323

[95] Zhang X,Fan T,Tan Y.A microfluidic biosensor based on multiple signal amplification for rapid and sensitive detection of E. coli O157:H7 and Staphylococcus aureus.Chin Chem Lett2026;37:111705

[96] Woolf M,Karas S.Characterization of a centrifugal microfluidic orthogonal flow platform.Micromachines2022;13:487 PMCID:PMC8950265

[97] Dignan LM,Mighell IK,Landers JP.A novel method for inward fluid displacement in centrifugal microdevices for highly integrated nucleic acid processing with long-term reagent storage.Anal Chim Acta2022;1221:340063

[98] Chen B,Xu F.Powerful CRISPR-based biosensing techniques and their integration with microfluidic platforms.Front Bioeng Biotechnol2022;10:851712 PMCID:PMC8905290

[99] Zhang Y,Liu G.Portable all-in-one microfluidic system for CRISPR-Cas13a-based fully integrated multiplexed nucleic acid detection.Lab Chip2024;24:3367-76

[100] Hu H,Zhang L.A PAM-free and universal CRISPR-Cas12a activation model for ultra-sensitive DNA methylation detection.Chin Chem Lett2026;37:111184

[101] Shu T,Xiong Q.Lift-CM: an integrated lift-heater centrifugal microfluidic platform for point-of-care pathogen nucleic acid detection using isothermal amplification and CRISPR/Cas12a.Biosens Bioelectron2025;274:117178

[102] Li J,Song Z.Palm-sized CRISPR sensing platform for on-site mycoplasma pneumoniae detection.Biosens Bioelectron2025;281:117458

[103] Hu F,Yang Y.A rapid and ultrasensitive RPA-assisted CRISPR-Cas12a/Cas13a nucleic acid diagnostic platform with a smartphone-based portable device.Biosens Bioelectron2025;280:117428

[104] Avaro AS.A critical review of microfluidic systems for CRISPR assays.Lab Chip2023;23:938-63

[105] Nafian F,Hobabi Aghmiuni M.Emerging microfluidic technologies for CRISPR-based diagnostics: an overview.Anal Methods2025;17:1962-76

[106] Peleg-Chen D,Brio L.Microfluidic tool for rapid functional characterization of CRISPR complexes.New Biotechnol2022;68:1-8 PMCID:PMC8891023

[107] Cui S,Yang Y,Li X.An integrated and paper-based microfluidic system employing LAMP-CRISPR and equipped with a portable device for simultaneous detection of pathogens.Anal Bioanal Chem2024;417:785-97

[108] Zhao M,Ye H.Digital microfluidics actuated multiplexed heterogeneous immunoassay with enhanced automation and efficiency.Chin Chem Lett2026;37:111788

[109] Li Z,Xie L,Jiang X.Automated microfluidic nucleic acid detection platform-integrated RPA-T7-Cas13a for pathogen diagnosis.Anal Chem2023;95:6940-7

[110] Wang Y,He B,Li J.A dual-signal amplification strategy combining DNA-functionalized covalent organic frameworks and CRISPR-Cas12a for early detection of ovarian cancer biomarkers.Chin Chem Lett2026;37:112061

[111] Li Y,Chen J.Detection of SARS-CoV-2 based on artificial intelligence-assisted smartphone: A review.Chin Chem Lett2024;35:109220

[112] Oboma YI,Charles M.A, Kenneth E.M. Review on gene and cell therapies in prostate cancer treatment: prospects and challenges.J Transl Genet Genom2025;9:62-75

[113] Li Z,Yin K,Ballesteros E.Instrument-free, CRISPR-based diagnostics of SARS-CoV-2 using self-contained microfluidic system.Biosens Bioelectron2022;199:113865 PMCID:PMC8653405

[114] Tan LL.Electrochemical aptamer-based biosensors for sepsis diagnosis: recent advances, challenges, and future perspectives (2020-2025).Biosensors2025;15:402 PMCID:PMC12292998

[115] Chen F.CRISPR/Cas-mediated macromolecular DNA methylation editing: Precision targeting of DNA methyltransferases in cancer therapy.Int J Biol Macromol2025;308:142401

[116] Tian W,Niu X.CRISPR/Cas12a-mediated DNAzyme/split-aptamer cascade for label-free detection of site-specific DNA methylation.Biosens Bioelectron2025;287:117720

[117] Broto M,Adrianus C.Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs.Nat Nanotechnol2022;17:1120-6 PMCID:PMC7616987

[118] Liu Y,Jiang K.Near-infrared light responsive upconversion-DNA nanocapsules for remote-controlled CRISPR-Cas9 genome editing.Chin Chem Lett2025;36:110282

[119] Choi MY,Choi J.Intracellular biosensors by functional nanomaterial-integrated CRISPR technologies for real-time molecular sensing.Chem Commun2026;62:58-70

[120] Zhang Y,Zhang J.Formation mechanism for stable system of nanoparticle/protein corona and phospholipid membrane.Chin Chem Lett2024;35:108619

[121] Escalona-Noguero C,Sot B.CRISPR/Cas technology as a promising weapon to combat viral infections.Bioessays2021;43:2000315 PMCID:PMC7995209

[122] Xie S,Suo T,Zhang X.Advancing sensing technology with CRISPR: from the detection of nucleic acids to a broad range of analytes - a review.Anal Chim Acta2021;1185:338848

[123] Luo X,Xue Y,Zhou J.Digital PCR-free technologies for absolute quantitation of nucleic acids at single-molecule level.Chin Chem Lett2025;36:109924